News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
486,108 Results
Type
Article (8016)
Company Profile (142)
Press Release (478219)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166768)
Career Advice (301)
Deals (25744)
Drug Delivery (7)
Drug Development (52789)
Employer Resources (14)
FDA (9754)
Job Trends (8565)
News (238121)
Policy (17875)
Tag
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (6)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (2)
2027 Pharm Country Digital (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (489)
Accelerated approval (26)
ADA (18)
Adcomms (1)
Allergies (98)
Alliances (33141)
ALS (113)
Alzheimer's disease (986)
Antibody-drug conjugate (ADC) (286)
Approvals (10411)
Artificial intelligence (340)
ASCO (159)
Autoimmune disease (224)
Automation (29)
Bankruptcy (263)
Belgium (1)
Best Places to Work (6952)
BIO (36)
Biologics (10)
BIOSECURE Act (1)
Biosimilars (116)
BioSpace Insights (17)
Biotechnology (90)
Bispecific (1)
Bladder cancer (140)
Brain cancer (31)
Breast cancer (521)
Cancer (3788)
Cardiovascular disease (227)
Career advice (242)
Career pathing (1)
CAR-T (180)
CDC (1)
CDMO (20)
Celiac Disease (1)
Cell therapy (492)
Cervical cancer (35)
Clinical research (48015)
Collaboration (1288)
Commercialization (3)
Compensation (1538)
Complete response letters (34)
COVID-19 (760)
CRISPR (64)
C-suite (810)
Cystic fibrosis (87)
Data (5907)
Denatured (4)
Depression (107)
Dermatology (71)
Diabetes (362)
Diagnostics (4226)
Digital health (39)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (160)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (166)
Earnings (73811)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (88173)
Executive appointments (716)
FDA (12513)
Fibrodysplasia Ossificans Progressiva (9)
Friedreich's ataxia (19)
Frontotemporal dementia (24)
Funding (957)
Gene editing (126)
Generative AI (11)
Gene therapy (335)
GLP-1 (295)
Government (944)
Grass and pollen (2)
Guidances (281)
Healthcare (9363)
Hematology (94)
HIV (55)
Huntington's disease (23)
IgA nephropathy (70)
Immunology and inflammation (108)
Immuno-oncology (61)
Indications (164)
Infectious disease (952)
Inflammatory bowel disease (130)
Inflation Reduction Act (4)
Influenza (85)
Intellectual property (265)
Interviews (41)
IPO (12394)
IRA (2)
Job creations (1967)
Job search strategy (232)
JPM (1)
Kidney cancer (17)
Kidney disease (46)
Layoffs (59)
Legal (5194)
Licensing (20)
Liver cancer (45)
Longevity (19)
Lung cancer (549)
Lymphoma (259)
Machine learning (29)
Management (3)
Manufacturing (581)
Marketing (8)
MASH (118)
Medical affairs (2)
Medical device (8681)
Medtech (8841)
Mergers & acquisitions (14414)
Metabolic disorders (736)
mRNA (65)
Multiple sclerosis (107)
NASH (4)
Neurodegenerative disease (228)
Neuropsychiatric disorders (40)
Neuroscience (1882)
NextGen: Class of 2026 (3147)
Non-profit (843)
Obesity (234)
Opinion (10)
Ovarian cancer (163)
Pain (178)
Pancreatic cancer (207)
Parkinson's disease (207)
Partnered (12)
Patents (505)
Patient recruitment (534)
Patient selection (3)
Peanut (32)
People (41371)
Peptides (3)
Pharmaceutical (30)
Pharmacy benefit managers (9)
Phase 1 (15509)
Phase 2 (21448)
Phase 3 (14461)
Pipeline (7799)
Policy (18)
Postmarket research (1559)
Preclinical (6554)
Press Release (34)
Prostate cancer (193)
Psychedelics (8)
Radiopharmaceuticals (195)
Rare diseases (593)
Real estate (3023)
Recruiting (6)
Regenerative medicine (2)
Regulatory (14976)
Reports (23)
Research institute (584)
Resumes & cover letters (45)
Rett syndrome (42)
RNA editing (5)
RSV (48)
Schizophrenia (104)
Series A (165)
Series B (123)
Service/supplier (5)
Sickle cell disease (63)
Spinal muscular atrophy (91)
Sponsored (5)
Startups (2020)
Stomach cancer (3)
Substance use disorders (16)
Supply chain (51)
Vaccines (320)
Venture capital (17)
Weight loss (75)
Women's health (90)
Date
Today (53)
Last 7 days (284)
Last 30 days (1486)
Last 365 days (19124)
2026 (13891)
2025 (19241)
2024 (22989)
2023 (26552)
2022 (34601)
2021 (37182)
2020 (33480)
2019 (23259)
2018 (17462)
2017 (18767)
2016 (17927)
2015 (24256)
2014 (21686)
2013 (18140)
2012 (20207)
2011 (20447)
2010 (20336)
Location
Africa (227)
Alabama (80)
Alaska (2)
Arizona (312)
Arkansas (10)
Asia (17953)
Australia (2093)
California (12420)
Canada (3258)
China (551)
Colorado (504)
Connecticut (428)
Delaware (216)
Europe (24642)
Florida (1868)
Georgia (393)
Hawaii (3)
Idaho (46)
Illinois (733)
India (52)
Indiana (326)
Iowa (16)
Japan (431)
Kansas (104)
Kentucky (32)
Louisiana (27)
Maine (26)
Maryland (1235)
Massachusetts (8133)
Michigan (315)
Minnesota (573)
Mississippi (4)
Missouri (83)
Montana (20)
Nebraska (11)
Nevada (124)
New Hampshire (60)
New Jersey (2717)
New Mexico (12)
New York (2914)
North Carolina (1322)
North Dakota (4)
Northern California (6245)
Ohio (297)
Oklahoma (14)
Oregon (16)
Pennsylvania (2307)
Puerto Rico (23)
Rhode Island (30)
South America (402)
South Carolina (78)
South Dakota (1)
Southern California (5175)
Tennessee (125)
Texas (2027)
United States (40258)
Utah (377)
Vermont (1)
Virginia (159)
Washington D.C. (39)
Washington State (960)
West Virginia (1)
Wisconsin (75)
Wyoming (1)
486,108 Results for "micropulse inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Iridex Announces New Thermal Dynamics Study That Strengthens Clinical Foundation and Market Potential of MicroPulse® Technology and Continuous-Wave Laser for Glaucoma Treatment
December 8, 2025
·
3 min read
Biotech Bay
Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust
Iridex Corporation today announced the first patient enrollment in a collaborative medical research study and registry evaluating the treatment of glaucoma with MicroPulse ® Transscleral Laser Therapy (TLT) using Iridex’ Cyclo G6 ® Laser and the MicroPulse P3 ® Delivery Device.
January 24, 2024
·
3 min read
Press Releases
Iridex Announces First Patient Enrolled in an Independent Landmark Investigator-Led UK Study Evaluating MicroPulse® Technology as an Adjunct to anti-VEGF Therapy for Diabetic Macular Edema
June 24, 2025
·
5 min read
Press Releases
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management
December 19, 2024
·
3 min read
Biotech Bay
Iridex Corporation Receives European Patent on MicroPulse TechnologyThe Advanced Short Pulse Laser System
Iridex Corporation (Nasdaq: IRIX) today announced the grant of the European Patent EP 3009093, entitled “Laser System with Short Pulse Characteristics and its Methods of Use”.
February 6, 2024
·
3 min read
Press Releases
Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026
August 4, 2026
·
1 min read
Press Releases
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
June 10, 2026
·
1 min read
Press Releases
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
July 29, 2026
·
4 min read
Biotech Bay
IRIDEX Announces MicroPulse Transscleral Laser Therapy Now Accepted in the European Glaucoma Society Guidelines
Guidelines provide recommendations on the diagnosis and management of glaucoma within the EU Nine MicroPulse TLT studies presented at the annual EGS meeting supporting its safety, effectiveness, and versatility in the treatment of glaucoma
December 22, 2020
·
4 min read
Press Releases
Allumiqs Solutions Inc. and Allumiqs Corporation
September 15, 2026
·
1 min read
1 of 48,611
Next
